Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the
Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at
Deans & Lyons
DALLAS, Oct. 18, 2013
DALLAS, Oct. 18, 2013 /PRNewswire/ --Securities lawyers at Deans & Lyons
announced a class action against the board of Cornerstone Therapeutics Inc.
(NASDAQ: CRTX) in connection with a buyout for $9.50 per share. ConcernedCRTX
investors should contact attorney Hamilton Lindley at 877-819-8033 or
email@example.com about their rights and remedies.
"Chiesi Farmaceutici has been a controlling shareholder since 2009 and
currently owns 58% of Cornerstone stock. Yahoo! Finance has valued Cornerstone
above the deal price consistently for the past month," said securities lawyer
Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that
all relevant information is disclosed and that the Cornerstone Therapeutics
Inc. shareholders receive the highest price reasonably available for their
Deans & Lyons has significant experience representing shareholders in
securities lawsuits nationwide. CRTX stockholders – or anyone with knowledge
about this situation – should contact lawyer Hamilton Lindley at
firstname.lastname@example.org or 877-819-8033 with questions or concerns.
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
SOURCE Deans & Lyons, LLP
Press spacebar to pause and continue. Press esc to stop.